ZAZIBONA is transitioning into a centralised process for the provision...
Read MoreLatest News
Check out our trending stories in Southern Africa.
A rapid assessment of the National Regulatory Systems for medical products in
The study aimed at analysing the regulatory systems for medical...
Read More
Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa
Introduction ZaZiBoNa, the work-sharing initiative in the Southern African Development...
Read More
Evaluation of the Good Review Practices of Countries Participating in the Southern
Introduction: National medicines regulatory agencies are faced with challenges including...
Read MoreLatest News
Check out our trending stories in Southern Africa.
Piloting of a Centralised Zazibona Joint Assessment Pathway for medicinal products
ZAZIBONA is transitioning into a centralised process for the provision...
Read More
A rapid assessment of the National Regulatory Systems for medical products in
The study aimed at analysing the regulatory systems for medical...
Read More
Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa
Introduction ZaZiBoNa, the work-sharing initiative in the Southern African Development...
Read More
Evaluation of the Good Review Practices of Countries Participating in the Southern
Introduction: National medicines regulatory agencies are faced with challenges including...
Read MoreAbout Zazibona
ZAZIBONA is a collaborative medicines registration initiative in Southern Africa focusing on dossier assessments and good manufacturing practice (cGMP) inspections.
ZAZIBONA was founded in October 2013 by four countries Zambia, Zimbabwe, Botswana and Namibia with the support of WHO prequalification and the Southern Africa Regional Program on Access to Medicines (SARPAM).
About Zazibona
ZAZIBONA is a collaborative medicines registration initiative in Southern Africa focusing on dossier assessments and good manufacturing practice (cGMP) inspections.
ZAZIBONA was founded in October 2013 by four countries Zambia, Zimbabwe, Botswana and Namibia with the support of WHO prequalification and the Southern Africa Regional Program on Access to Medicines (SARPAM).
Participating Countries
List of participating countries that make up Zazibona.
Our Scope of Products
The ZaZiBoNa initiative assesses and evaluates a wide range of products, including essential medicines and medications used in the treatment of priority diseases or conditions identified by the Southern African Development Community (SADC).
The eligible products encompass the following SADC priority diseases or conditions:- HIV/AIDS
- Tuberculosis
- Malaria
- Acute respiratory infections
- Diarrhoea
- Diabetes
- Pneumonia
- Cardiovascular
- Cancer
- Obstetrics
- Gastroenteritis and colic
- Reproductive health products
Products included in the list of United Nations Commission for Life-Saving Commodities for Women and Children Final UN Commission Report_14sept2012.pdf (unfpa.org) are also eligible.
More information is available under Eligibility Criteria located under Regional Collaborative Activities.
Our Scope of Products
Application Statistics for Zazibona.
The ZaZiBoNa initiative assesses and evaluates a wide range of products, including essential medicines and medications used in the treatment of priority diseases or conditions identified by the Southern African Development Community (SADC).
The eligible products encompass the following SADC priority diseases or conditions:- HIV/AIDS
- Tuberculosis
- Malaria
- Acute respiratory infections
- Diarrhoea
- Diabetes
- Pneumonia
- Cardiovascular
- Cancer
- Obstetrics
- Gastroenteritis and colic
- Reproductive health products
Products included in the list of United Nations Commission for Life-Saving Commodities for Women and Children Final UN Commission Report_14sept2012.pdf (unfpa.org) are also eligible.
Publications (Documents)
View a list of our latest publications